Literature DB >> 23913754

Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study.

Nellie Georgiou-Karistianis1, Julie C Stout, Juan F Domínguez D, Sarah P Carron, Ayaka Ando, Andrew Churchyard, Phyllis Chua, India Bohanna, Alicia R Dymowski, Govinda Poudel, Gary F Egan.   

Abstract

We used functional magnetic resonance imaging (fMRI) to investigate spatial working memory (WM) in an N-BACK task (0, 1, and 2-BACK) in premanifest Huntington's disease (pre-HD, n = 35), early symptomatic Huntington's disease (symp-HD, n = 23), and control (n = 32) individuals. Overall, both WM conditions (1-BACK and 2-BACK) activated a large network of regions throughout the brain, common to all groups. However, voxel-wise and time-course analyses revealed significant functional group differences, despite no significant behavioral performance differences. During 1-BACK, voxel-wise blood-oxygen-level-dependent (BOLD) signal activity was significantly reduced in a number of regions from the WM network (inferior frontal gyrus, anterior insula, caudate, putamen, and cerebellum) in pre-HD and symp-HD groups, compared with controls; however, time-course analysis of the BOLD response in the dorsolateral prefrontal cortex (DLPFC) showed increased activation in symp-HD, compared with pre-HD and controls. The pattern of reduced voxel-wise BOLD activity in pre-HD and symp-HD, relative to controls, became more pervasive during 2-BACK affecting the same structures as in 1-BACK, but also incorporated further WM regions (anterior cingulate gyrus, parietal lobe and thalamus). The DLPFC BOLD time-course for 2-BACK showed a reversed pattern to that observed in 1-BACK, with a significantly diminished signal in symp-HD, relative to pre-HD and controls. Our findings provide support for functional brain reorganisation in cortical and subcortical regions in both pre-HD and symp-HD, which are modulated by task difficulty. Moreover, the lack of a robust striatal BOLD signal in pre-HD may represent a very early signature of change observed up to 15 years prior to clinical diagnosis.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  DLPFC; Huntington's Disease; N BACK; fMRI; working memory

Mesh:

Substances:

Year:  2013        PMID: 23913754      PMCID: PMC6869353          DOI: 10.1002/hbm.22296

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  78 in total

1.  The distribution of structural neuropathology in pre-clinical Huntington's disease.

Authors:  M J Thieben; A J Duggins; C D Good; L Gomes; N Mahant; F Richards; E McCusker; R S J Frackowiak
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

2.  Dissociable executive functions in the dynamic control of behavior: inhibition, error detection, and correction.

Authors:  H Garavan; T J Ross; K Murphy; R A P Roche; E A Stein
Journal:  Neuroimage       Date:  2002-12       Impact factor: 6.556

3.  Prefrontal cortex and basal ganglia control access to working memory.

Authors:  Fiona McNab; Torkel Klingberg
Journal:  Nat Neurosci       Date:  2007-12-09       Impact factor: 24.884

4.  Temporal dynamics of brain activation during a working memory task.

Authors:  J D Cohen; W M Perlstein; T S Braver; L E Nystrom; D C Noll; J Jonides; E E Smith
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

5.  The assessment and analysis of handedness: the Edinburgh inventory.

Authors:  R C Oldfield
Journal:  Neuropsychologia       Date:  1971-03       Impact factor: 3.139

6.  Effects of depression on working memory in presymptomatic Huntington's disease.

Authors:  C Nehl; R E Ready; J Hamilton; J S Paulsen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

7.  Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia.

Authors:  Joseph H Callicott; Michael F Egan; Venkata S Mattay; Alessandro Bertolino; Ashley D Bone; Beth Verchinksi; Daniel R Weinberger
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

8.  Frontal lobe volume in patients with Huntington's disease.

Authors:  E H Aylward; N B Anderson; F W Bylsma; M V Wagster; P E Barta; M Sherr; J Feeney; A Davis; A Rosenblatt; G D Pearlson; C A Ross
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

9.  fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease.

Authors:  Jane S Paulsen; Janice L Zimbelman; Sean C Hinton; Douglas R Langbehn; Catherine L Leveroni; Michelle L Benjamin; Norman C Reynolds; Stephen M Rao
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

10.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

View more
  16 in total

1.  Activation volume vs BOLD signal change as measures of fMRI activation - Its impact on GABA - fMRI activation correlation.

Authors:  Pallab K Bhattacharyya; Micheal D Phillips; Lael A Stone; Mark J Lowe
Journal:  Magn Reson Imaging       Date:  2017-06-17       Impact factor: 2.546

2.  T1ρ imaging in premanifest Huntington disease reveals changes associated with disease progression.

Authors:  Shafik N Wassef; John Wemmie; Casey P Johnson; Hans Johnson; Jane S Paulsen; Jeffrey D Long; Vincent A Magnotta
Journal:  Mov Disord       Date:  2015-03-29       Impact factor: 10.338

3.  Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease.

Authors:  Robert Christian Wolf; Philipp Arthur Thomann; Fabio Sambataro; Nadine Donata Wolf; Nenad Vasic; G Bernhard Landwehrmeyer; Sigurd Dietrich Süßmuth; Michael Orth
Journal:  J Neurol       Date:  2015-01-28       Impact factor: 4.849

4.  Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington's disease: the IMAGE-HD study.

Authors:  Brendan Tan; Rosita Shishegar; Stuart Oldham; Alex Fornito; Govinda Poudel; Nellie Georgiou-Karistianis
Journal:  Brain Imaging Behav       Date:  2022-06-29       Impact factor: 3.978

5.  Large-scale brain network abnormalities in Huntington's disease revealed by structural covariance.

Authors:  Lora Minkova; Simon B Eickhoff; Ahmed Abdulkadir; Christoph P Kaller; Jessica Peter; Elisa Scheller; Jacob Lahr; Raymund A Roos; Alexandra Durr; Blair R Leavitt; Sarah J Tabrizi; Stefan Klöppel
Journal:  Hum Brain Mapp       Date:  2015-10-10       Impact factor: 5.038

6.  Executive functions in premanifest Huntington's disease.

Authors:  S Christine You; Michael D Geschwind; Sharon J Sha; Alexandra Apple; Gabriella Satris; Kristie A Wood; Erica T Johnson; Jonathan Gooblar; Jeanne S Feuerstein; Steven Finkbeiner; Gail A Kang; Bruce L Miller; Christopher P Hess; Joel H Kramer; Katherine L Possin
Journal:  Mov Disord       Date:  2013-12-27       Impact factor: 10.338

7.  Network topology and functional connectivity disturbances precede the onset of Huntington's disease.

Authors:  Deborah L Harrington; Mikail Rubinov; Sally Durgerian; Lyla Mourany; Christine Reece; Katherine Koenig; Ed Bullmore; Jeffrey D Long; Jane S Paulsen; Stephen M Rao
Journal:  Brain       Date:  2015-06-09       Impact factor: 13.501

8.  The role of the amygdala during emotional processing in Huntington's disease: from pre-manifest to late stage disease.

Authors:  Sarah L Mason; Jiaxiang Zhang; Faye Begeti; Natalie Valle Guzman; Alpar S Lazar; James B Rowe; Roger A Barker; Adam Hampshire
Journal:  Neuropsychologia       Date:  2015-02-17       Impact factor: 3.139

Review 9.  Neuroimaging in Huntington's disease.

Authors:  Flavia Niccolini; Marios Politis
Journal:  World J Radiol       Date:  2014-06-28

10.  Abnormal Electrophysiological Motor Responses in Huntington's Disease: Evidence of Premanifest Compensation.

Authors:  Lauren M Turner; Rodney J Croft; Andrew Churchyard; Jeffrey C L Looi; Deborah Apthorp; Nellie Georgiou-Karistianis
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.